Premium
Otoacoustic emission testing in Ghanaian children with sickle‐cell disease
Author(s) -
Kegele Josua,
Hurth Helene,
Lackner Peter,
Enimil Anthony,
Sylverkin Justice,
Ansong Daniel,
Nkyi Clara,
Bonsu Benedicta,
Agbenyega Tsiri,
Schartinger Volker H.,
Schmutzhard Erich,
Zorowka Patrick,
Kremsner Peter,
Schmutzhard Joachim
Publication year - 2015
Publication title -
tropical medicine and international health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.056
H-Index - 114
eISSN - 1365-3156
pISSN - 1360-2276
DOI - 10.1111/tmi.12533
Subject(s) - medicine , hemoglobinopathy , disease , sickle cell anemia , pediatrics , pathology
Abstract Objective To evaluate hearing loss in children as a complication of sickle‐cell disease. Methods In Kumasi, Ghana, 35 children with SCD aged 6 months to 10 years underwent transient‐evoked otoacoustic emissions testing ( TEOAE ) to investigate the function of the inner ear. Healthy Ghanaian children recruited in school and kindergarten served as controls. Results One of 35 children with SCD and 13 of 115 control children failed the otoacoustic emissions testing. This difference between the control group and the children with SCD was not statistically significant. Conclusion Early hearing impairment does not regularly occur in sickle‐cell disease, and in children, it is not a likely cause of delayed or impaired language development.